SuFey Ong

5.7k total citations
19 papers, 780 citations indexed

About

SuFey Ong is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Oncology. According to data from OpenAlex, SuFey Ong has authored 19 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 9 papers in Immunology and 7 papers in Oncology. Recurrent topics in SuFey Ong's work include Viral Infections and Immunology Research (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). SuFey Ong is often cited by papers focused on Viral Infections and Immunology Research (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). SuFey Ong collaborates with scholars based in United States, Italy and Switzerland. SuFey Ong's co-authors include Daniela Čiháková, Noel R. Rose, Monica V. Talor, Jobert G. Barin, G. Christian Baldeviano, Djahida Bedja, Lei Wu, Nicola Laura Diny, David A. Kass and Hao Zhang and has published in prestigious journals such as Nature Genetics, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

SuFey Ong

19 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SuFey Ong United States 13 300 290 203 151 113 19 780
Martin Butcher Canada 17 259 0.9× 79 0.3× 228 1.1× 182 1.2× 87 0.8× 23 862
Kathleen Pappritz Germany 15 197 0.7× 477 1.6× 289 1.4× 69 0.5× 192 1.7× 31 757
Dean Kavanagh United Kingdom 15 209 0.7× 53 0.2× 245 1.2× 116 0.8× 172 1.5× 30 876
Ann McCormack United Kingdom 14 200 0.7× 164 0.6× 128 0.6× 39 0.3× 184 1.6× 29 600
J.M. Bachaud France 10 129 0.4× 200 0.7× 79 0.4× 272 1.8× 102 0.9× 35 833
Jochen T. Schaefer United States 11 430 1.4× 82 0.3× 151 0.7× 480 3.2× 50 0.4× 17 802
P Libby United States 8 458 1.5× 78 0.3× 144 0.7× 80 0.5× 222 2.0× 11 775
Yvonne Talke Germany 14 614 2.0× 50 0.2× 189 0.9× 104 0.7× 127 1.1× 18 1.0k
Aya Shibamiya Germany 12 205 0.7× 164 0.6× 348 1.7× 20 0.1× 285 2.5× 18 1.1k
Vincent Lok United States 5 213 0.7× 189 0.7× 124 0.6× 105 0.7× 50 0.4× 10 571

Countries citing papers authored by SuFey Ong

Since Specialization
Citations

This map shows the geographic impact of SuFey Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SuFey Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SuFey Ong more than expected).

Fields of papers citing papers by SuFey Ong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SuFey Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SuFey Ong. The network helps show where SuFey Ong may publish in the future.

Co-authorship network of co-authors of SuFey Ong

This figure shows the co-authorship network connecting the top 25 collaborators of SuFey Ong. A scholar is included among the top collaborators of SuFey Ong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SuFey Ong. SuFey Ong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mallardo, Domenico, Andrew White, Margaret Ottaviano, et al.. (2023). CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy. Journal of Translational Medicine. 21(1). 610–610. 19 indexed citations
2.
Simeone, Ester, Giosuè Scognamiglio, Mariaelena Capone, et al.. (2021). A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation. Journal of Translational Medicine. 19(1). 17–17. 5 indexed citations
3.
Awada, Gil, Julia Katharina Schwarze, Yanina Jansen, et al.. (2020). Baseline biomarkers correlated with outcome in advanced melanoma treated with pembrolizumab monotherapy.. Journal of Clinical Oncology. 38(15_suppl). e22041–e22041. 3 indexed citations
4.
Leskelä, Susanna, Belén Perez‐Mies, Juan Manuel Rosa-Rosa, et al.. (2019). Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma. Cancers. 11(7). 964–964. 58 indexed citations
5.
Danaher, Patrick, et al.. (2019). A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity. Journal for ImmunoTherapy of Cancer. 7(1). 15–15. 20 indexed citations
6.
Kok, Marleen, Leonie Voorwerk, Hugo M. Horlings, et al.. (2018). Adaptive phase II randomized trial of nivolumab after induction treatment in triple negative breast cancer (TONIC trial): Final response data stage I and first translational data.. Journal of Clinical Oncology. 36(15_suppl). 1012–1012. 34 indexed citations
7.
Capone, Mariaelena, Gabriele Madonna, Paolo A. Ascierto, et al.. (2018). Abstract 558: Prognostic gene signature use in checkpoint inhibitor monotherapy for melanoma. Cancer Research. 78(13_Supplement). 558–558. 1 indexed citations
8.
Barin, Jobert G., Monica V. Talor, Nicola Laura Diny, et al.. (2017). Regulation of autoimmune myocarditis by host responses to the microbiome. Experimental and Molecular Pathology. 103(2). 141–152. 16 indexed citations
9.
Diny, Nicola Laura, G. Christian Baldeviano, Monica V. Talor, et al.. (2017). Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy. The Journal of Experimental Medicine. 214(4). 943–957. 69 indexed citations
10.
Ong, SuFey, Noel R. Rose, & Daniela Čiháková. (2016). Natural killer cells in inflammatory heart disease. Clinical Immunology. 175. 26–33. 73 indexed citations
11.
Ong, SuFey, Mathias Hauri‐Hohl, & Steven F. Ziegler. (2016). The role of c-Ski and TGFβ signaling in autoimmunity. The Journal of Immunology. 196(1_Supplement). 186.7–186.7. 1 indexed citations
12.
Hobbs, Ryan P., Daryle J. DePianto, Justin T. Jacob, et al.. (2015). Keratin-dependent regulation of Aire and gene expression in skin tumor keratinocytes. Nature Genetics. 47(8). 933–938. 94 indexed citations
13.
Ong, SuFey, Davinna L. Ligons, Jobert G. Barin, et al.. (2015). Natural Killer Cells Limit Cardiac Inflammation and Fibrosis by Halting Eosinophil Infiltration. American Journal Of Pathology. 185(3). 847–861. 73 indexed citations
14.
Wu, Lei, Nicola Laura Diny, SuFey Ong, et al.. (2015). Pathogenic IL‐23 signaling is required to initiate GM‐CSF‐driven autoimmune myocarditis in mice. European Journal of Immunology. 46(3). 582–592. 34 indexed citations
15.
Wu, Lei, SuFey Ong, Monica V. Talor, et al.. (2014). Cardiac fibroblasts mediate IL-17A–driven inflammatory dilated cardiomyopathy. The Journal of Experimental Medicine. 211(7). 1449–1464. 141 indexed citations
16.
Barin, Jobert G., G. Christian Baldeviano, Monica V. Talor, et al.. (2013). Fatal Eosinophilic Myocarditis Develops in the Absence of IFN-γ and IL-17A. The Journal of Immunology. 191(8). 4038–4047. 50 indexed citations
17.
Ong, SuFey, Davinna L. Ligons, Jobert G. Barin, et al.. (2012). Natural killer cells suppress cardiac eosinophilia in autoimmune myocarditis (171.21). The Journal of Immunology. 188(1_Supplement). 171.21–171.21. 1 indexed citations
18.
Baldeviano, G. Christian, Jobert G. Barin, Lei Wu, et al.. (2012). IL6 is necessary for the progression of experimental autoimmune myocarditis to dilated cardiomyopathy (171.11). The Journal of Immunology. 188(1_Supplement). 171.11–171.11. 1 indexed citations
19.
Barin, Jobert G., G. Christian Baldeviano, Monica V. Talor, et al.. (2011). Macrophages participate in IL‐17‐mediated inflammation. European Journal of Immunology. 42(3). 726–736. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Butcher Breakdown of academic impact, for papers by Kathleen Pappritz Breakdown of academic impact, for papers by Dean Kavanagh Breakdown of academic impact, for papers by Ann McCormack Breakdown of academic impact, for papers by J.M. Bachaud Breakdown of academic impact, for papers by Jochen T. Schaefer Breakdown of academic impact, for papers by P Libby Breakdown of academic impact, for papers by Yvonne Talke Breakdown of academic impact, for papers by Aya Shibamiya Breakdown of academic impact, for papers by Vincent Lok
Rankless by CCL
2026